FR2944106B1 - Methode de dosage de l'inositol hexaphosphate (ihp). - Google Patents

Methode de dosage de l'inositol hexaphosphate (ihp).

Info

Publication number
FR2944106B1
FR2944106B1 FR0952208A FR0952208A FR2944106B1 FR 2944106 B1 FR2944106 B1 FR 2944106B1 FR 0952208 A FR0952208 A FR 0952208A FR 0952208 A FR0952208 A FR 0952208A FR 2944106 B1 FR2944106 B1 FR 2944106B1
Authority
FR
France
Prior art keywords
ihp
determining
inositol hexaphosphate
hexaphosphate
inositol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0952208A
Other languages
English (en)
Other versions
FR2944106A1 (fr
Inventor
Vanessa Bourgeaux
Yann Godfrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phaxiam Therapeutics SA
Original Assignee
Erytech Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0952208A priority Critical patent/FR2944106B1/fr
Application filed by Erytech Pharma SA filed Critical Erytech Pharma SA
Priority to CA2757407A priority patent/CA2757407A1/fr
Priority to SG2011071677A priority patent/SG175019A1/en
Priority to CN2010800196290A priority patent/CN102428367A/zh
Priority to AU2010233803A priority patent/AU2010233803B2/en
Priority to PCT/EP2010/054516 priority patent/WO2010115880A1/fr
Priority to US13/262,408 priority patent/US20120129210A1/en
Priority to KR1020117025994A priority patent/KR20120014898A/ko
Priority to EP10713899A priority patent/EP2414831A1/fr
Priority to JP2012502712A priority patent/JP2012522978A/ja
Publication of FR2944106A1 publication Critical patent/FR2944106A1/fr
Priority to IL215466A priority patent/IL215466A0/en
Application granted granted Critical
Publication of FR2944106B1 publication Critical patent/FR2944106B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]
FR0952208A 2009-04-03 2009-04-03 Methode de dosage de l'inositol hexaphosphate (ihp). Expired - Fee Related FR2944106B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0952208A FR2944106B1 (fr) 2009-04-03 2009-04-03 Methode de dosage de l'inositol hexaphosphate (ihp).
EP10713899A EP2414831A1 (fr) 2009-04-03 2010-04-06 Méthode de dosage de l'inositol hexaphosphate (ihp)
CN2010800196290A CN102428367A (zh) 2009-04-03 2010-04-06 测定肌醇六磷酸（ihp）的方法
AU2010233803A AU2010233803B2 (en) 2009-04-03 2010-04-06 Method for assaying inositol hexaphosphate (IHP)
PCT/EP2010/054516 WO2010115880A1 (fr) 2009-04-03 2010-04-06 Méthode de dosage de l'inositol hexaphosphate (ihp)
US13/262,408 US20120129210A1 (en) 2009-04-03 2010-04-06 Method for Assaying Inositol Hexaphosphate (IHP)
CA2757407A CA2757407A1 (fr) 2009-04-03 2010-04-06 Methode de dosage de l'inositol hexaphosphate (ihp)
SG2011071677A SG175019A1 (en) 2009-04-03 2010-04-06 Method for assaying inositol hexaphosphate (ihp)
JP2012502712A JP2012522978A (ja) 2009-04-03 2010-04-06 イノシトール六リン酸（ｉｈｐ）をアッセイするための方法
KR1020117025994A KR20120014898A (ko) 2009-04-03 2010-04-06 이노시톨 헥사포스페이트（ｉｈｔ）를 분석하는 방법
IL215466A IL215466A0 (en) 2009-04-03 2011-10-02 Method for assaying inositol hexaphosphate (ihp)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0952208A FR2944106B1 (fr) 2009-04-03 2009-04-03 Methode de dosage de l'inositol hexaphosphate (ihp).

Publications (2)

Publication Number Publication Date
FR2944106A1 FR2944106A1 (fr) 2010-10-08
FR2944106B1 true FR2944106B1 (fr) 2012-09-28

Family

ID=41134708

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0952208A Expired - Fee Related FR2944106B1 (fr) 2009-04-03 2009-04-03 Methode de dosage de l'inositol hexaphosphate (ihp).

Country Status (11)

Country Link
US (1) US20120129210A1 (fr)
EP (1) EP2414831A1 (fr)
JP (1) JP2012522978A (fr)
KR (1) KR20120014898A (fr)
CN (1) CN102428367A (fr)
AU (1) AU2010233803B2 (fr)
CA (1) CA2757407A1 (fr)
FR (1) FR2944106B1 (fr)
IL (1) IL215466A0 (fr)
SG (1) SG175019A1 (fr)
WO (1) WO2010115880A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
AU2011289579B2 (en) 2010-08-10 2016-11-17 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP2796152A1 (fr) * 2013-04-25 2014-10-29 Bayer Pharma Aktiengesellschaft Complexes au Bis Azainositol Hafnium asymétriques pour imagerie par rayons X
WO2015073587A2 (fr) 2013-11-18 2015-05-21 Rubius Therapeutics, Inc. Complexes membrane synthétique- récepteur
FR3017299B1 (fr) 2014-02-12 2018-05-18 Erytech Pharma Composition pharmaceutique comprenant des erythrocytes encapsulant une enzyme a plp et son cofacteur
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
BR112016019274A2 (pt) 2014-02-21 2017-10-10 Anokion Sa agentes terapêuticos glico-orientados
EP3125927B1 (fr) 2014-04-01 2021-01-27 Rubius Therapeutics, Inc. Méthodes et compositions d'immunomodulation
CN108778298A (zh) 2016-01-11 2018-11-09 鲁比厄斯治疗法股份有限公司 与免疫适应症的多模式治疗性细胞体系有关的组合物和方法
EP3638296A1 (fr) 2017-06-16 2020-04-22 The University Of Chicago Compositions et procédés d'induction d'une tolérance immunitaire
CN112326848B (zh) * 2020-10-23 2022-11-29 杭州师范大学 一种基于三甲基硅基重氮甲烷甲酯化植酸分析方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
JPH08294A (ja) * 1994-06-23 1996-01-09 Fujirebio Inc イノシトール三燐酸の測定方法及び試薬
AU8379998A (en) * 1997-07-07 1999-02-08 Exseed Genetics L.L.C. Animal feed with low phytic acid, oil burdened and protein laden grain
AU6912500A (en) * 1999-08-25 2001-03-19 Gmp Companies, Inc. Enhanced oxygen delivery in mammals, methods and reagents related thereto
CA2488230C (fr) * 2002-04-29 2013-04-09 Yves Claude Nicolau Inositol pyrophosphates et procede d'utilisation desdits composes
JP2004275087A (ja) * 2003-03-17 2004-10-07 Yoshikuni Ito フィチン酸カルシウムの加水分解によるイノシトールの製造方法
FR2873925B1 (fr) 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
KR20070099519A (ko) * 2004-09-17 2007-10-09 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 3가 금속 매개 균질 발광 근접 분석

Also Published As

Publication number Publication date
SG175019A1 (en) 2011-11-28
JP2012522978A (ja) 2012-09-27
KR20120014898A (ko) 2012-02-20
WO2010115880A1 (fr) 2010-10-14
AU2010233803B2 (en) 2014-05-15
EP2414831A1 (fr) 2012-02-08
CA2757407A1 (fr) 2010-10-14
FR2944106A1 (fr) 2010-10-08
US20120129210A1 (en) 2012-05-24
IL215466A0 (en) 2011-12-29
AU2010233803A1 (en) 2011-11-10
CN102428367A (zh) 2012-04-25

Similar Documents

Publication Publication Date Title
FR2944106B1 (fr) Methode de dosage de l'inositol hexaphosphate (ihp).
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
IL238571A0 (en) Broton tyrosine kinase inhibitors, preparations containing them and their uses
EP2925740A4 (fr) Inhibiteurs de la tyrosine kinase de bruton
ZA201308397B (en) Inhibitors of bruton's tyrosine kinase
ZA201300705B (en) Inhibitors of bruton's tyrosine kinase
ZA201209381B (en) The use of inhibitors of bruton's tyrosine kinase (btk)
EP2731612A4 (fr) Inhibiteurs de tyrosine kinase de bruton
ES2590905T8 (es) Inhibidores de la tirosina quinasa de Bruton
IL230561A0 (en) Broton tyrosine kinase inhibitors
EP2858500A4 (fr) Inhibiteurs de la tyrosine kinase de bruton
DK3556277T3 (da) Engangssugeventil til et endoskop
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
ZA201301160B (en) Asparaginase from basidiomycetes
DK2537351T3 (da) Fremgangsmåde til den binaurale laterale opfattelse for høreinstrumenter
BR112015005788A2 (pt) implante de articulação".
IT1400545B1 (it) Procedimento per la preparazione di tessuto biologico per protesi biologiche.
ITBO20110590A1 (it) Procedimento e apparecchiatura per l'estrazione di bava di chiocciola.
IT1404454B1 (it) Procedimento per la realizzazione di sbozzati per scatole su misura.
IT1400714B1 (it) Processo ed intermedi per la preparazione di un principio attivo.
IT1403282B1 (it) Procedimento per la preparazione di linagliptin
IT1402029B1 (it) Procedimento per la preparazione di erlotinib
IT1401164B1 (it) Procedimento per la determinazione del numero di giri
IT1405996B1 (it) Procedimento per la preparazione di 2,5-diaminotoluolo
ITTO20110857A1 (it) Procedimento per la produzione di cicloesanonossina.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231